Characteristics of patients with enhancing intracranial atherosclerosis and association between plaque enhancement and recent cerebrovascular ischemic events: a high-resolution magnetic resonance imaging study

Abstract

Background

Atherosclerotic plaque inflammation is a well-known risk factor for the development of ischemic stroke.

Purpose

To investigate the characteristics of patients with enhancing intracranial atherosclerosis and the relationship between plaque enhancement and recent cerebrovascular ischemic events by using high-resolution magnetic resonance imaging (HR-MRI).

Material and Methods

A total of 141 patients (102 men; mean age = 61.1 ± 11.4 years) with intracranial atherosclerotic plaque who underwent HR-MRI were enrolled in this study. The contrast ratio (CR) and contrast enhancement of the plaques were measured. Binary logistic regression was used to estimate the association between plaque enhancement and clinical and plaque characteristics. The relationship between plaque enhancement and recent ischemic events was evaluated by multivariate logistic regression analysis.

Results

Of 141 patients, plaque enhancement was detected in 80 (56.7%). Compared to patients without plaque enhancement, those with plaque enhancement had significantly lower level of high-density lipoprotein cholesterol, greater maximum plaque length, and more severe luminal stenosis. Luminal stenosis was independently associated with plaque enhancement (odds ratio [OR] = 1.026; 95% confidence interval [CI] = 1.014–1.039). Multivariate regression analysis showed that plaque enhancement was an independent indicator for recent ischemic events after adjusting for confounding factors (OR = 9.521; 95% CI = 4.301–19.900) (all P < 0.05).

Conclusion

Luminal stenosis is independently associated with plaque enhancement. We observed a strong association between plaque enhancement and recent ischemic events, which suggests that plaque enhancement may serve as an indicator of its instability.

Keywords

Arteriosclerosis magnetic resonance imaging vascular ischemia/infarction

Get full access to this article

View all access options for this article.

References

Holmstedt

Turan

Chimowitz

MI.

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.

Lancet Neurol 2013; 12:1106–1114.

Chen

Gao

Wang

, et al. Classifying ischemic stroke, from TOAST to CISS. CNS Neurosci Ther 2012; 18:452–456.

Chimowitz

Lynn

Derdeyn

, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365:993–1003.

Hong

K-S

Yegiaian

Lee

, et al. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation 2011; 123:2111–2119.

Huang

Gao

, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997; 48:524–525.

Caplan

Gorelick

Hier

DB.

Race, sex and occlusive cerebrovascular disease: a review.

Stroke 1986; 17:648–655.

Chung

Kwak

Hwang

, et al. High resolution MR imaging in patients with symptomatic middle cerebral artery stenosis. Eur J Radiol 2012; 81:4069–4074.

Vakil

Vranic

Hurley

, et al. T1 gadolinium enhancement of intracranial atherosclerotic plaques associated with symptomatic ischemic presentations. Am J Neuroradiol 2013; 34:2252–2258.

Skarpathiotakis

Mandell

Swartz

, et al. Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke. Am J Neuroradiol 2013; 34:299–304.

10.

Willerson

Ridker

PM.

Inflammation as a cardiovascular risk factor.

Circulation 2004; 109:2–10.

11.

Ibrahim

Makowski

Jankauskas

, et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imaging 2009; 2:580–588.

12.

Millon

Boussel

Brevet

, et al. Clinical and histological significance of gadolinium enhancement in carotid atherosclerotic plaque. Stroke 2012; 43:3023–3028.

13.

Gupta

Baradaran

Al-Dasuqi

, et al. Gadolinium enhancement in intracranial atherosclerotic plaque and ischemic stroke: a systematic review and meta-analysis. J Am Heart Assoc 2016; 5:e003816.

14.

Qiao

Etesami

Astor

, et al. Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events. Am J Neuroradiol 2012; 33:755–760.

15.

Greenberg

MS.

Handbook of Neurosurgery. New York: Thieme Medical Publishers, 2010.

16.

Natori

Sasaki

Miyoshi

, et al. Evaluating middle cerebral artery atherosclerotic lesions in acute ischemic stroke using magnetic resonance T1-weighted 3-dimensional vessel wall imaging. J Stroke Cerebrovasc Dis 2014; 23:706–711.

17.

Chimowitz

Kokkinos

Strong

, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45:1488–1493.

18.

Kim

Jung

Sohn

, et al. Intracranial plaque enhancement from high resolution vessel wall magnetic resonance imaging predicts stroke recurrence. Int J Stroke 2016; 11:171–179.

19.

Takano

Hida

Kuwabara

, et al. Intracranial arterial wall enhancement using gadolinium-enhanced 3D black-blood T1-weighted imaging. Eur J Radiol 2017; 86:13–19.

20.

Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003; 22:106–117.

21.

Cai

Hatsukami

Ferguson

, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005; 112:3437–3444.

22.

Lou

, et al. Contrast-enhanced 3T high-resolution MR imaging in symptomatic atherosclerotic basilar artery stenosis. Am J Neuroradiol 2013; 34:513–517.

23.

Qiao

Zeiler

Mirbagheri

, et al. Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images. Radiology 2014; 271:534–542.

24.

Zhao

Deng

Xie

, et al. High-resolution MRI of the vessel wall in patients with symptomatic atherosclerotic stenosis of the middle cerebral artery. J Clin Neurosci 2015; 22:700–704.

25.

Chen

, et al. Magnetic resonance imaging of plaque burden in vascular walls of the middle cerebral artery correlates with cerebral infarction. Curr Neurovasc Res 2016; 13:263–270.

26.

Shan

Gao

, et al. In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis 2010; 212:507–511.

27.

Dieleman

Yang

Abrigo

, et al. Magnetic resonance imaging of plaque morphology, burden, and distribution in patients with symptomatic middle cerebral artery stenosis. Stroke 2016; 47:1797–1802.

28.

Natori

Sasaki

Miyoshi

, et al. Intracranial plaque characterization in patients with acute ischemic stroke using pre- and post-contrast three-dimensional magnetic resonance vessel wall imaging. J Stroke Cerebrovasc Dis 2016; 25:1425–1430.

29.

Klein

Lavallee

Mazighi

, et al. Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke 2010; 41:1405–1409.